Evidence map›Paper›PMID 42795304›Full record

ArticleLife (Basel, Switzerland)2026

Could Hepcidin Be a Phenotype-Related Biomarker in Patients with Stable Bronchiectasis?

Gulcin Yilmaz Gunes, Hikmet Çoban, Fuat Erel, Merve Akış Yılmaz, Nurhan Sarioglu, Mustafa Colak, Merve Yumrukuz Senel, Ayşe Dilvin Mansır Elmalı

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gulcin Yilmaz GunesDepartment of Pulmonology, Bandırma Training and Research Hospital, 10145 Balıkesir, Türkiye.ORCID 0009-0004-3487-7721
Hikmet ÇobanDepartment of Pulmonology, Faculty of Medicine, Balıkesir University, 10145 Balıkesir, Türkiye.
Fuat ErelDepartment of Pulmonology, Faculty of Medicine, Balıkesir University, 10145 Balıkesir, Türkiye.
Merve Akış YılmazDepartment of Medical Biochemistry, Faculty of Medicine, Balıkesir University, 10145 Balıkesir, Türkiye.ORCID 0000-0002-5338-7355
Nurhan SariogluDepartment of Pulmonology, Faculty of Medicine, Balıkesir University, 10145 Balıkesir, Türkiye.ORCID 0000-0002-5180-9649
Mustafa ColakDepartment of Pulmonology, Faculty of Medicine, Balıkesir University, 10145 Balıkesir, Türkiye.ORCID 0000-0002-8458-3535
Merve Yumrukuz SenelDepartment of Pulmonology, Faculty of Medicine, Balıkesir University, 10145 Balıkesir, Türkiye.ORCID 0000-0003-0205-5075
Ayşe Dilvin Mansır ElmalıDepartment of Pulmonology, Faculty of Medicine, Balıkesir University, 10145 Balıkesir, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepcidin centrally regulates iron homeostasis and responds to inflammation, iron status, hypoxia, and erythropoietic signaling, yet circulating hepcidin in stable bronchiectasis is poorly characterized. We compared serum hepcidin between 61 patients with stable bronchiectasis and 39 controls without bronchiectasis and assessed associations with anemia, iron metabolism, systemic inflammation, severity, and phenotype. Hepcidin was lower in bronchiectasis (20.34 ± 7.85 vs. 28.34 ± 9.82 ng/mL; median, 20.31 [15.07-25.35] vs. 25.03 [21.00-34.66] ng/mL;

Indexed as

anemiabiomarkerbronchiectasishepcidininflammation

Identifiers

PMID42795304
PMCPMC13608646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.